TPWA
WVE icon

Twin Peaks Wealth Advisors’s Wave Life Sciences WVE Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5
Closed -$36 – 2241
2026
Q1 		$36 Buy
+5
New +$65 ﹤0.01% 2322
2025
Q3 		– Sell
-4
Closed -$34 – 2169
2025
Q2 		$34 Buy
+4
New +$26 ﹤0.01% 2214

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Twin Peaks Wealth Advisors's WVE Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 5 shares — an estimated $36 sold.

Twin Peaks Wealth Advisors first reported a position in WVE in Q2 2025 and held it in 2 quarters. The position peaked at $36 in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 5 Wave Life Sciences shares in Q2 2026, an estimated $36.
  • Twin Peaks Wealth Advisors first reported a position in Wave Life Sciences in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's Wave Life Sciences position peaked at $36 in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.